EKF Diagnostics Holdings plc (LON:EKF - Get Free Report)'s share price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 23.93 ($0.32) and traded as high as GBX 26.90 ($0.36). EKF Diagnostics shares last traded at GBX 25.20 ($0.33), with a volume of 2,253,335 shares changing hands.
EKF Diagnostics Trading Up 1.9%
The company has a market cap of £114.10 million, a P/E ratio of 23.89 and a beta of 0.57. The stock's 50-day moving average is GBX 21.11 and its two-hundred day moving average is GBX 23.93. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.60 and a quick ratio of 1.77.
EKF Diagnostics (LON:EKF - Get Free Report) last issued its quarterly earnings data on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) earnings per share for the quarter. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%. As a group, equities research analysts predict that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current fiscal year.
Insider Activity at EKF Diagnostics
In other EKF Diagnostics news, insider Gavin T. Jones purchased 50,000 shares of the firm's stock in a transaction on Tuesday, March 25th. The shares were acquired at an average cost of GBX 22 ($0.29) per share, for a total transaction of £11,000 ($14,592.73). 5.24% of the stock is owned by insiders.
EKF Diagnostics Company Profile
(
Get Free Report)
EKF is an AIM-listed global diagnostics business focussed on:
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider EKF Diagnostics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EKF Diagnostics wasn't on the list.
While EKF Diagnostics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
